AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION（Assistance Publique Hopitaux De Marseille）

N/A

Report date: 2022/06/17 16:19:06

Base Information

Drug NameAUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION（Assistance Publique Hopitaux De Marseille）

Drug Alias NameADSVF

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsVocal Cord Dysfunction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAssociation Sportive De L Assistance Publique Hopitaux De Marseille

China Registration ClassN/A

Develop Information

Active CompaniesAssociation Sportive De L Assistance Publique Hopitaux De Marseille

Inactive CompaniesN/A

Active IndicationsVocal Cord Dysfunction

Inactive IndicationsN/A

Other Information

ATC CodeN/A